These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6672502

  • 1. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
    Dooley JS, Gooding A, Hamilton-Miller JM, Brumfitt W, Sherlock S.
    Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
    [Abstract] [Full Text] [Related]

  • 2. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R, Gundert-Remy U, Raedsch R, Sieg A, Stiehl A.
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [Abstract] [Full Text] [Related]

  • 3. The biliary excretion of sulphated and non-sulphated bile acids and bilirubin in patients with external bile drainage.
    Dooley JS, Bartholomew C, Summerfield JA, Billing BH.
    Clin Sci (Lond); 1984 Jul; 67(1):61-8. PubMed ID: 6734078
    [Abstract] [Full Text] [Related]

  • 4. [Biliary excretion of mezlocillin].
    Rösch W, Stock KP, Burkhardt F.
    Fortschr Med; 1981 Jan 22; 99(3):76-8. PubMed ID: 6451569
    [Abstract] [Full Text] [Related]

  • 5. [Bile composition and antibiotic excretion. Observations with T-drainage].
    Rosenthal RJ, Steigerwald SD, Bockhorn H.
    Z Gesamte Inn Med; 1993 Jan 22; 48(1):18-22. PubMed ID: 8095119
    [Abstract] [Full Text] [Related]

  • 6. Kinetics of mezlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U, Förster D, Schacht P, Weber E.
    J Antimicrob Chemother; 1982 Jan 22; 9 Suppl A():65-75. PubMed ID: 6210684
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
    Maeba T, Hashimoto T, Takeda T, Shiraishi Y, Oike H, Wakabayashi H, Omori G, Indo S, Kunikata E, Hayashi M.
    Jpn J Antibiot; 1986 Jan 22; 39(1):116-20. PubMed ID: 3702053
    [Abstract] [Full Text] [Related]

  • 8. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
    Kobayashi N, Tanimura H, Huang WF, Sekiya T, Takahashi H, Sato T, Yoshida K, Hikasa Y.
    Jpn J Antibiot; 1984 Apr 22; 37(4):597-604. PubMed ID: 6471380
    [Abstract] [Full Text] [Related]

  • 9. Bile acid synthesis and excretion following release of total extrahepatic cholestasis by percutaneous transhepatic drainage.
    Eklund A, Norlander A, Norman A.
    Eur J Clin Invest; 1980 Oct 22; 10(5):349-55. PubMed ID: 6777167
    [Abstract] [Full Text] [Related]

  • 10. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime.
    Leung JW, Chan RC, Cheung SW, Sung JY, Chung SC, French GL.
    J Antimicrob Chemother; 1990 Mar 22; 25(3):399-406. PubMed ID: 2187012
    [Abstract] [Full Text] [Related]

  • 11. [Comparative biliary excretion of mezlocillin and 12 other beta-lactam antibiotics (author's transl)].
    Comte F, Brogard JM, Kopferschmitt J, Dorner M, Lavillaureix J.
    Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):353-60. PubMed ID: 6460975
    [Abstract] [Full Text] [Related]

  • 12. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.
    Levi JU, Martinez OV, Malinin TI, Zeppa R, Livingstone A, Hutson D, Calhoun P.
    Antimicrob Agents Chemother; 1984 Dec 04; 26(6):944-6. PubMed ID: 6524908
    [Abstract] [Full Text] [Related]

  • 13. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
    Gundert-Remy U, Hildebrandt R, Stiehl A, Weber E.
    Clin Pharmacol Ther; 1983 May 04; 33(5):656-62. PubMed ID: 6220858
    [Abstract] [Full Text] [Related]

  • 14. Differences in biliary lipid excretion after major hepatectomy in obstructive jaundiced rats with preoperative internal, external, or no biliary drainage.
    Mizuta A, Chijiiwa K, Saiki S, Kuroki S, Nakamura K, Tanaka M.
    Eur Surg Res; 2002 May 04; 34(4):291-9. PubMed ID: 12145555
    [Abstract] [Full Text] [Related]

  • 15. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice.
    Chijiiwa K, Watanabe M, Nakano K, Noshiro H, Tanaka M.
    Am J Surg; 2000 Feb 04; 179(2):161-6. PubMed ID: 10773154
    [Abstract] [Full Text] [Related]

  • 16. Effect of ursodeoxycholate on the biliary excretion of cefotiam and sulbenicillin in patients with percutaneous transhepatic biliary drainage.
    Higashi K, Hayakawa T, Katagiri K, Tsukada K, Ito K, Hoshino M, Miyaji M, Takeuchi T, Yamamoto T.
    Antimicrob Agents Chemother; 1988 May 04; 32(5):726-9. PubMed ID: 3164988
    [Abstract] [Full Text] [Related]

  • 17. Diurnal variation in the biliary excretion of flomoxef in patients with percutaneous transhepatic biliary drainage.
    Hishikawa S, Kobayashi E, Sugimoto K, Miyata M, Fujimura A.
    Br J Clin Pharmacol; 2001 Jul 04; 52(1):65-8. PubMed ID: 11453891
    [Abstract] [Full Text] [Related]

  • 18. The effect of biliary decompression on antibiotic biliary excretion.
    Yamamoto S, Kubota Y, Takaoka M, Ogura M, Tsuji K, Yanagitani K, Shimatani M, Shibatani N, Imai Y, Takamidoh S, Inoue K.
    Hepatogastroenterology; 2002 Jul 04; 49(44):330-4. PubMed ID: 11995444
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
    Meyers BR, Srulevitch ES, Sacks HS, Hirschman SZ, Worner TM, Wormser GP, Jacobson J.
    J Antimicrob Chemother; 1986 Dec 04; 18(6):709-13. PubMed ID: 3818496
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of refractory malignant biliary obstraction: comparing results of percutaneous transhepatic biliary drainage with external catheters or endoscopic metallic stenting].
    Zou XP, Zhan XB, Li ZS, Jin ZD, Wan XJ, Wang N, Xu GM.
    Zhonghua Nei Ke Za Zhi; 2004 Feb 04; 43(2):109-11. PubMed ID: 15059407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.